Skip to search formSkip to main contentSkip to account menu

esmolol

Known as: esmolol [Chemical/Ingredient], 3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester, (±)-esmolol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
In this randomized, double-blind, controlled study, we tested the hypothesis that the short-acting &bgr;1-adrenoceptor… 
Highly Cited
2001
Highly Cited
2001
Background: Measurements of intrathoracic blood volume (ITBV) provide volumetric information about cardiac preload and are used… 
Highly Cited
1998
Highly Cited
1998
Esmolol, a short-acting beta1-receptor antagonist, decreases anesthetic requirements during propofol/N2 O/morphine anesthesia… 
Highly Cited
1991
Highly Cited
1991
In 97 outpatients undergoing ambulatory arthroscopic procedures, we compared esmolol with alfentanil when used to supplement… 
Highly Cited
1990
Highly Cited
1990
Forty-five patients of ASA physical status 1 and II undergoing a variety of non-cardiac surgical procedures were studied to… 
Highly Cited
1990
Highly Cited
1990
The effectiveness of esmolol, an ultra short-acting cardioselective β blocker, in the prevention and treatment of post-intubation… 
Highly Cited
1989
Highly Cited
1989
The circulatory response to a 30-second laryngoscopy followed by orotracheal intubation was recorded in 60 patients of ASA… 
Highly Cited
1986
Highly Cited
1986
We evaluated the effects of esmolol, a short acting (t½ β = 9 min) β-blocker on hemodynamics during noxious stimulation…